USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Cassiopea S.P.A.

USPTO PatentsView assignee record - 14 granted patents across 5 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

RSS updates for this company

The verdict

According to USPTO PatentsView, Cassiopea ranks #19,573 of 49,997 tracked US assignees by granted-patent volume, with 14 patents across 5 technology areas.

#19,573
of 49,997 US assignees by volume
45th percentile
by Innovation Score (33.7/100)
20.7
avg claims per patent
+17%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R19573 · Foreign Corporation #19,573 · 14 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-FRNCORP · VEL-UP · BOOK-FULL

  • GRANTS-MICRO 14 grants
  • MID-PACK #19,573/49,997
  • PHOTO-FINISH Capsule
  • CPC-NARROW A61P · 5 areas
  • INNOV-THIN 33.7/100
  • CLAIMS-DENSE 20.7 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-UP +17% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Capsule Technologies, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Cassiopea

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Cassiopea's Innovation Score is 33.7/100 (45th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Cassiopea's grants concentrate

Cassiopea S.P.A. is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2016 (2 grants) versus a trough of 1 in 2015. By volume, Cassiopea sits between Capsule Technologies, Inc. and Cecelumen, LLC.

Cassiopea's three-year grant acceleration

Cassiopea S.P.A. shows 3 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Cassiopea's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Cassiopea holds 14 patents at rank #19,561, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Cassiopea

By rank, the assignees closest to #19,561 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Cassiopea's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Cassiopea, neither rank-band nor same-CPC leaders (those blocks stay above).

Cassiopea's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 45th percentile higher than 45% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.5 201520162018201920202021202220242025 1
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Cassiopea S.P.A. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 1 7.1%
2016 2 14.3%
2018 2 14.3%
2019 1 7.1%
2020 2 14.3%
2021 2 14.3%
2022 1 7.1%
2024 2 14.3%
2025partial year 1 7.1%

Where it ranks

Overall rank by patents

#19,573

of 49,997 tracked assignees

Innovation Score

33.7 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Cassiopea S.P.A.'s patent record in context - here's where to go next.

  • Cassiopea S.P.A.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
  • Ranked #19,573 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Cassiopea S.P.A. against Capsule Technologies, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 33.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.